Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹184 Cr
up ₹15.9 Cr vs Feb 2019
- Stocks held
- 23
- down 2 vs Feb 2019
- Top 10 weight
- 59.2%
- of the portfolio in its ten largest
- Cash & debt
- 9.2%
- cash, money market and debt
- Moves this month
- 0 in · 2 out
- added to 10, trimmed 6
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In March 2019 it disclosed 23 stocks worth ₹184 Cr, up ₹15.9 Cr from Feb 2019. Its largest positions were Sun Pharmaceutical Industries Limited (13.5%), IPCA Laboratories Limited (8.4%), Dr. Reddy's Laboratories Limited (8.1%); the ten largest together made up 59.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 70.6% of its equity. Cash and debt stood at 9.2%. Compared with Feb 2019 the fund entered 0 new stocks and exited 2.
Against 229 other Sectoral / Thematic funds
Concentration
81%
Top-10 weight is higher than 81% of peers
Breadth
6%
Holds more stocks than 6% of peers
Cash
92%
Holds more cash than 92% of peers
What these mean: concentration · cash
Holdings in March 2019
Download CSVEvery line the fund disclosed, with the change against Feb 2019. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 13.45% | up 3.83 pts | ₹24.7 Cr | up ₹8.6 Cr | Added |
| Cash, TREPS & receivables | 9.23% | down 3.87 pts | ₹16.9 Cr | down ₹5 Cr | Trimmed |
| IPCA Laboratories Limited | 8.44% | up 0.82 pts | ₹15.5 Cr | up ₹2.7 Cr | Added |
| Dr. Reddy's Laboratories Limited | 8.06% | up 0.23 pts | ₹14.8 Cr | up ₹1.7 Cr | Added |
| Apollo Hospitals Enterprise Limited | 5.06% | up 1.09 pts | ₹9.3 Cr | up ₹2.6 Cr | Added |
| Divi's Laboratories Limited | 4.93% | down 0.31 pts | ₹9.1 Cr | up ₹26 L | Added |
| JB Chemicals & Pharmaceuticals Limited | 4.35% | up 0.06 pts | ₹8 Cr | up ₹80 L | Added |
| Indoco Remedies Limited | 4.28% | up 0.26 pts | ₹7.9 Cr | up ₹1.1 Cr | Added |
| Unichem Laboratories Limited | 4.01% | down <0.01 pts | ₹7.4 Cr | up ₹64 L | Added |
| Procter & Gamble Health Limited | 3.51% | up 0.23 pts | ₹6.4 Cr | up ₹95 L | Added |
| Aarti Drugs Limited | 3.12% | down 0.04 pts | ₹5.7 Cr | up ₹43 L | Added |
| Ajanta Pharma Limited | 2.98% | up 0.09 pts | ₹5.5 Cr | up ₹63 L | Added |
| Jubilant Pharmova Limited | 2.90% | down 0.42 pts | ₹5.3 Cr | down ₹25 L | Trimmed |
| Alkem Laboratories Limited | 2.84% | down 0.58 pts | ₹5.2 Cr | down ₹52 L | Trimmed |
| Alembic Pharmaceuticals Limited | 2.76% | down 0.39 pts | ₹5.1 Cr | down ₹21 L | Trimmed |
| Abiomed Inc | 2.75% | up 0.97 pts | ₹5.1 Cr | up ₹2.1 Cr | Added |
| Torrent Pharmaceuticals Limited | 2.71% | down 0.03 pts | ₹5 Cr | up ₹38 L | Added |
| Abbott Laboratories | 2.54% | up 1.56 pts | ₹4.7 Cr | up ₹3 Cr | Added |
| Abbott India Limited | 2.53% | down 0.29 pts | ₹4.6 Cr | down ₹8 L | Trimmed |
| Max India Limited | 2.34% | down 1.06 pts | ₹4.3 Cr | down ₹1.4 Cr | Trimmed |
| Syngene International Limited | 2.18% | up 0.13 pts | ₹4 Cr | up ₹57 L | Added |
| ICICI Lombard General Insurance Company Limited | 2.09% | up 0.03 pts | ₹3.8 Cr | up ₹38 L | Added |
| Lupin Limited | 1.54% | down 0.20 pts | ₹2.8 Cr | down ₹9 L | Trimmed |
| Dr. Lal Path Labs Limited | 1.40% | down 0.08 pts | ₹2.6 Cr | up ₹8 L | Added |
What changed, Feb 2019 to Mar 2019
New New positions (0)
None.
Exited Exited (2)
- Cipla Limitedwas 1.8% · ₹3 Cr
- Sun Pharma Advanced Research Company Limitedwas 0.3% · ₹42 L
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹8.6 Cr (+3.83% pts)
- Abbott Laboratoriesup ₹3 Cr (+1.56% pts)
- IPCA Laboratories Limitedup ₹2.7 Cr (+0.82% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Feb 2019, the weight rose most in Pharmaceuticals (+1.6 pts) and Healthcare Services (+0.5 pts), and fell most in Pharmaceuticals & Biotechnology (−2.0 pts).
- Pharmaceuticals10.4% → 11.9%+1.6 pts
- Healthcare Services14.6% → 15.1%+0.5 pts
- Pharmaceuticals & Biotechnology72.7% → 70.6%−2.0 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2018 | Feb 2019 | Mar 2019 |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 69.9% | 72.7% | 70.6% |
| Healthcare Services | 16.6% | 14.6% | 15.1% |
| Pharmaceuticals | 10.7% | 10.4% | 11.9% |
| Insurance | 2.7% | 2.4% | 2.3% |
Allocation in Mar 2019change vs Feb 2019
- Pharmaceuticals & Biotechnology (14)70.6%▼ 2.0 pts
- Healthcare Services (5)15.1%▲ 0.5 pts
- Pharmaceuticals (3)11.9%▲ 1.6 pts
- Insurance (1)2.3%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Mar 2019
9.2%
▼ 3.9 pts vs Feb 2019
- Cash alone
- 9.2%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 9.2% – 28.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.